CClinicalTrials.gg
CompletedNCT01402635POCTEDUpdated Jul 24, 2012

Can the Point-Of-Care Chemistry Test (POCT) Solve the Emergency Department (ED) Crowding?

An interventional study of point-of-care chemistry test(POCT) (Piccolo) in Crowding, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2012-07-24.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
10,244
Allocation
Randomized
Ages
15 Years and older
Sex
All
01

Study summary

The hypothesis of this study that the Point-Of-Care Chemistry Test (POCT) may shorten Emergency Department (ED) length of stay (LOS).

Read the detailed description

ED crowding is one of the most serious problems in ED. POCT has shorter turn-around time compared to centralized laboratory system. If POCT introduce to ED, it may help to shorten LOS of ED patients.

02

Conditions studied

  • Crowding

Browse trials for

Keywords

  • crowding
  • Point-of-Care Systems
  • emergency medicine
03

In context

Emergencies

1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.

This study's enrollment of 10,244 is above the median of 145 across 931 interventional studies indexed under Emergencies.

Browse Emergencies studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients older than 15 years
  • clinically required to have chemistry lab tests
  • ESI 2-5
  • written agreement to participate

Exclusion criteria

Exclusion Criteria:

  • no agreement
  • ESI level 1
  • no chemistry lab
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
10,244 participants (actual)

Study arms

  • Experimental
    POCT lab

    The patient group whose laboratory test perform by POCT chemistry analyzer.

    Device: point-of-care chemistry test(POCT) (Piccolo)

  • Active comparator
    central laboratory group(CLT)

    The patients group whose laboratory test perform by central laboratory.

    Device: point-of-care chemistry test(POCT) (Piccolo)

Interventions

  • Devicepoint-of-care chemistry test(POCT) (Piccolo)

    comprehensive chemistry POCT including ALB, ALP, ALT, AST, BUN, Ca, Cl-, Cre, Glu, K+, Na+, TBil, TCO2, TP It takes 12minutes to perform analyze.

    Also known as: Piccolo® xpress, Piccolo® Comprehensive Metabolic Reagent Disc

06

What researchers measure

Primary outcomes

  1. length of stay

    Time interval between registration at ED and leaving at ED(discharge, admission, etc.)

    Time frame: average 7days from ED visit(up to time of discharge at ED or admission to ward)

Secondary outcomes

  1. length of stay(subgroup)

    length of stay analysis for Emergency Severity Index (ESI) 3-4, admission or discharge group

    Time frame: average 7days from ED visit (up to time of discharge at ED or admission to ward)

07

Study locations

1 site
  • Seoul National University Hospital
    Seoul, 110-744, Korea, Republic of
08

References and documents

Publications

  • Lee EJ, Shin SD, Song KJ, Kim SC, Cho JS, Lee SC, Park JO, Cha WC. A point-of-care chemistry test for reduction of turnaround and clinical decision time. Am J Emerg Med. 2011 Jun;29(5):489-95. doi: 10.1016/j.ajem.2009.11.020. Epub 2010 Apr 24. PubMed 20825817 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 24, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01402635
Lead sponsor
Seoul National University Hospital
Responsible party
Sang Do Shin (Associated professor, Seoul National University Hospital) — Principal investigator
First posted
Jul 26, 2011
Start date
Jan 2011
Primary completion
Aug 2011
Completion
Aug 2011
Last update
Jul 24, 2012

Study contacts

Sang Do Shin, MD, PhD
principal investigator · Seoul National University Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion